Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
14 nov 2014 - 12:45
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug: Capital increase from authorized capital in connection with the Greenshoe option has been completed
Bericht
This announcement is not an offer to sell, or a solicitation of an offer to acquire any securities. This announcement is not a prospectus and investors should not purchase any securities referred to in this announcement except on the basis of information in the prospectus published by Probiodrug AG as approved by the competent German regulator Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) on 10 October 2014 and passported to the Dutch Authority for Financial Markets (Autoriteit Financiële Markten) in connection with the Initial Public Offering and admission to trading of its shares on Euronext Amsterdam.
Capital increase from authorized capital in connection with the Greenshoe option has been completed
Gerelateerde downloads
Datum laatste update: 02 september 2024